Skip to content
ppharmaranks
Menu
Class IIOngoing

Atomoxetine Capsules HCL recall

FDA recall D-0538-2026 · initiated Apr 30, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated May 27, 2026How we research

Safecor Health, LLC recalled Atomoxetine Capsules HCL in Apr 2026 — an FDA Class II recall (D-0538-2026) because Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule.

Labelling, packaging or a product mix-up

The wrong information — or the wrong medicine — ended up in the pack. A mix-up is a manufacturing failure that can still be dangerous to swallow.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot #: 25530722

Quantity recalled: 149 capsules

Details

Product
Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip, strips are packed in cartons of 100, Rx Only, Pkg by: Safecor, Columbus, OH 43204. NDC: 64380-474-01
Recalling company
Safecor Health, LLC
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
TX only
Initiated
Apr 30, 2026
FDA report date
May 27, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Atomoxetine Capsules HCL recalled?
Safecor Health, LLC recalled Atomoxetine Capsules HCL in Apr 2026 — an FDA Class II recall (D-0538-2026) because Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Atomoxetine Capsules HCL recalled?
Per the FDA enforcement record, the reason for recall D-0538-2026 was: Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule.
Is a recalled Atomoxetine Capsules HCL dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Atomoxetine Capsules HCL are affected?
Distributed: TX only. The recall covers these lots — Lot #: 25530722. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0538-2026.

Source: openFDA Drug Enforcement record D-0538-2026

← All drug recalls